Tirzepatide is a promising new drug belonging to the GLP-1 and GIP Receptor Agonist classes of drugs that has recently been approved by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It appears as an alternative to Ozempic (Semaglutide), which has rapidly become a popular weight-loss medication among […]Read More
In order to achieve and maintain a lower bodyweight, be it for aesthetic or health-related reasons, people often try various methods, including the use of medications that, although initially designed to help with type-2 diabetes, also aid in weight loss. Two very important options in this class are Mounjaro (tirzepatide) and Ozempic (semaglutide). This article […]Read More
© 2024 Steroidify. All rights reserved. Privacy Policy. Contact Us.
